Organisation paid for research Program year 2025 Source: CMS Open Payments

Alpine Research Organization, Inc

Neither a doctor nor a teaching hospital

Research payments

$1,525,505

43 payments

Through program year 2025, Alpine Research Organization, Inc is reported as receiving $1,525,505 in research payments, across 43 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$14,298	3
2024	Research	$572,608	17
2023	Research	$909,303	22
2022	Research	$29,297	1

Breakdown

Who paid Research payments · program years 2022–2025

Moderna TX, Inc. $1,511,207 40 payments
Alnylam Pharmaceuticals Inc. $14,298 3 payments

Studies the money was for Research payments · program years 2022–2025

A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), in Adults 60 Years of Age $1,511,207 40 payments
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease $14,298 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.